Xilio Therapeutics
XLO
$1.14
Share price
5.56%
Change (1 day)
-63.58%
Change (1 year)
Categories
Xilio Therapeutics (XLO) - Cash on Hand
Cash on Hand as of September 2023 : $59.77 M
According to Xilio Therapeutics's latest financial reports the company has $59.77 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Xilio Therapeutics - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.12 B | -39.22% |
| 2021-12-31 | $0.19 B | 929.49% |
| 2020-12-31 | $19.23 M | -60.61% |
| 2019-12-31 | $48.84 M |